Pharmaceuticals News and Research

RSS
Advances in nanotechnology point to next generation of prostheses

Advances in nanotechnology point to next generation of prostheses

New form of intravenous iron treats anemia in chronic kidney disease patients on dialysis

New form of intravenous iron treats anemia in chronic kidney disease patients on dialysis

New bone cement may prevent amputations

New bone cement may prevent amputations

Mylan receives final FDA approvals for generic Lamictal tablets

Mylan receives final FDA approvals for generic Lamictal tablets

SAFC Pharma augments assay development capabilities

SAFC Pharma augments assay development capabilities

Early treatment with rasagiline (Azilect) for Parkinson's best

Early treatment with rasagiline (Azilect) for Parkinson's best

Second degree nurses are an efficient new solution to the current nursing shortage

Second degree nurses are an efficient new solution to the current nursing shortage

Opposite approach to asthma treatment may be in order

Opposite approach to asthma treatment may be in order

Researchers develop "virtual patient" to help train the pharmacists of the future

Researchers develop "virtual patient" to help train the pharmacists of the future

Protease inhibitor found to aid diabetic retinopathy treatment

Protease inhibitor found to aid diabetic retinopathy treatment

Loss of sex drive after menopause affects health, quality of life

Loss of sex drive after menopause affects health, quality of life

Physicians counsel their overweight type 2 diabetes patients to lose weight - many not listening

Physicians counsel their overweight type 2 diabetes patients to lose weight - many not listening

Cell transplantation and diabetes: New sites, new devices

Cell transplantation and diabetes: New sites, new devices

WHO receives funds for children's medicines research with UNICEF

WHO receives funds for children's medicines research with UNICEF

Water pollution linked to male fertility problems

Water pollution linked to male fertility problems

Poxvirus breakthrough

Poxvirus breakthrough

Eli Lilly to pay $1.415 billion for off-label promotion of Zyprexa

Eli Lilly to pay $1.415 billion for off-label promotion of Zyprexa

New drug shows promise for phenylketonuria

New drug shows promise for phenylketonuria

Half of people 50 years and younger with low 10-year risk of CVD have high lifetime risk

Half of people 50 years and younger with low 10-year risk of CVD have high lifetime risk

Cell Therapeutics targeting potential Zevalin label expansion,

Cell Therapeutics targeting potential Zevalin label expansion,

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.